Immunoregulatory potential of exopolysaccharide from Lactobacillus rhamnosus KL37. Effects on the production of inflammatory mediators by mouse macrophages
- 22 September 2011
- journal article
- research article
- Published by Wiley in International Journal of Experimental Pathology
- Vol. 92 (6) , 382-391
Abstract
The ability to produce exopolysaccharides (EPS) is widespread among lactobacilli including Lactobacillus rhamnosus, the commonly used probiotic bacteria. Exopolysaccharides are a major component of the bacterial biofilm with a well-documented impact on adherence of bacteria to host cells. However, their immunoregulatory properties are unknown. The aim of this study was to examine the immunostimulatory potential of EPS derived from L. rhamnosus KL37. We investigated the effect of EPS on the production of inflammatory mediators by mouse peritoneal macrophages and compared it with the effect of Lipopolysaccharide (LPS). Exopolysaccharides, at concentrations higher than those of LPS, stimulated production of both pro-inflammatory (TNF-α, IL-6, IL-12) and anti-inflammatory (IL-10) cytokines. Interestingly, analysis of the balance of TNF-α/IL-10 production showed a potential pro-inflammatory effect of EPS. Furthermore, our data demonstrate that exposure of macrophages to LPS induced a state of hyporesponsiveness, as indicated by reduced production of TNF-α after restimulation with either LPS or EPS (‘cross-tolerance’). By contrast, EPS could make cells tolerant only to subsequent stimulation by the same stimulus. We also examined the relationship between TNF-α production and activation of mitogen-activated protein kinases (MAPKs) by EPS and LPS. Pretreatment of macrophages with specific inhibitors of p38 and ERK MAPKs reduced TNF-α production induced by both stimuli to the same extent. In conclusion, these data demonstrate that EPS can effectively stimulate production of inflammatory mediators by macrophages in vitro. However, to predict whether EPS could be clinically useful as an immunomodulatory agent, further in vivo studies with highly purified EPS are necessary.Keywords
This publication has 40 references indexed in Scilit:
- Interaction of orally administered Lactobacillus rhamnosus GG with skin and gut microbiota and humoral immunity in infants with atopic dermatitisClinical & Experimental Allergy, 2010
- Lactobacillus GG as Treatment for Diarrhea During Enteral Feeding in Critical IllnessJournal of Parenteral and Enteral Nutrition, 2010
- The Effect of Exopolysaccharide-Producing Probiotic Strains on Gut Oxidative Damage in Experimental ColitisDigestive Diseases and Sciences, 2010
- Bacterial Extracellular Polysaccharides Involved in Biofilm FormationMolecules, 2009
- Bifidobacterium longum PL03, Lactobacillus rhamnosus KL53A, and Lactobacillus plantarum PL02 in the Prevention of Antibiotic-Associated Diarrhea in Children: A Randomized Controlled Pilot TrialDigestion, 2008
- The EPS Matrix: The “House of Biofilm Cells”Journal of Bacteriology, 2007
- Differential inflammatory mediator response in vitro from murine macrophages to lactobacilli and pathogenic intestinal bacteriaInternational Journal of Experimental Pathology, 2007
- Lipoteichoic acid fromLactobacillus plantarumelicits both the production of Interleukin-23p19 and suppression of pathogen-mediated Interleukin-10 in THP-1 cellsFEMS Immunology & Medical Microbiology, 2007
- Lipoteichoic Acids fromLactobacillusStrains Elicit Strong Tumor Necrosis Factor Alpha-Inducing Activities in Macrophages through Toll-Like Receptor 2Clinical and Vaccine Immunology, 2003
- MAP Kinases in the Immune ResponseAnnual Review of Immunology, 2002